
Seraph Biosciences, Inc.: A Detroit-based biomedical device firm, innovating in diagnostic technology since 2014.
Seraph Biosciences, Inc., founded in 2014 and headquartered in Detroit, Michigan, is a biomedical device company focused on revolutionizing diagnostic technology. Their core mission is to provide real-time pathogen detection at the point of care using their innovative Seraspec® technology. By leveraging Raman Spectroscopy, Seraspec® offers a portable solution for the rapid screening and identification of bacterial, viral, and fungal pathogens, eliminating the need for traditional, time-consuming laboratory methods.
Notable affiliates and investors include key figures from the biomedical and tech industries who have supported the development and commercialization of Seraspec®. The company has achieved significant milestones, including securing patents for their technology and gaining recognition for their contributions to point-of-care diagnostics. Seraph Biosciences' impact lies in its potential to transform pathogen detection, making it faster, more efficient, and accessible, thereby improving patient outcomes and healthcare efficiency.

Spectral Platforms

PhageTech
phagetech.com

Spectrafluidics

Seraxis
seraxis.com

Sapphiros
sapphiros.com

Sedia Biosciences
sediabio.com

ECI Biotech
ecibiotech.com

Seraphina Therapeutics

PathoGene

OmniVis

GeneCapture
genecapture.com

BioFluidica
biofluidica.com

Seranova Bio
seranovabio.com

Persperion Diagnostics
persperiontech.com

MagBiosense
magbiosense.com
Companies similar to Seraph Biosciences include Spectral Platforms, PhageTech, Spectrafluidics and Seraxis.
Seraph Biosciences was founded in 2014.
Seraph Biosciences' headquarters is located in Detroit, MI, US.
As of Jan 1, 2020, Seraph Biosciences has raised a total of $9.2M (USD).
Seraph Biosciences has 11 employees as of Feb 5, 2024.